Literature DB >> 22675790

The history of the Department of Internal Medicine at Saint Louis University.

Adrian M Di Bisceglie1, Connie Manning, Assako Holyoke.   

Abstract

The Department of Internal Medicine at Saint Louis University has a long and proud tradition of excellence in patient care, research and education that goes back for 100 years, but also appears to remain strong for the future. The department has played a key role in several medical discoveries and innovations over the last 100 years and continues to make an impact on those in its community.

Entities:  

Mesh：

Year:  2012        PMID： 22675790      PMCID： PMC6181749     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  8 in total

1.  Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.

Authors:  R B Belshe; W C Gruber
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

3.  EPIDEMIOLOGY OF SAINT LOUIS ENCEPHALITIS.

Authors:  A E Casey; G O Broun
Journal:  Science       Date:  1938-11-11       Impact factor: 47.728

Review 4.  Role of interventional nephrology in dialysis access management.

Authors:  Srinath Tamirisa; Rakesh Patel; Kevin J Martin
Journal:  Mo Med       Date:  2011 Jul-Aug

5.  Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice.

Authors:  V B Kumar; S A Farr; J F Flood; V Kamlesh; M Franko; W A Banks; J E Morley
Journal:  Peptides       Date:  2000-12       Impact factor: 3.750

6.  Boceprevir for previously treated chronic HCV genotype 1 infection.

Authors:  Bruce R Bacon; Stuart C Gordon; Eric Lawitz; Patrick Marcellin; John M Vierling; Stefan Zeuzem; Fred Poordad; Zachary D Goodman; Heather L Sings; Navdeep Boparai; Margaret Burroughs; Clifford A Brass; Janice K Albrecht; Rafael Esteban
Journal:  N Engl J Med       Date:  2011-03-31       Impact factor: 91.245

7.  Telaprevir for previously untreated chronic hepatitis C virus infection.

Authors:  Ira M Jacobson; John G McHutchison; Geoffrey Dusheiko; Adrian M Di Bisceglie; K Rajender Reddy; Natalie H Bzowej; Patrick Marcellin; Andrew J Muir; Peter Ferenci; Robert Flisiak; Jacob George; Mario Rizzetto; Daniel Shouval; Ricard Sola; Ruben A Terg; Eric M Yoshida; Nathalie Adda; Leif Bengtsson; Abdul J Sankoh; Tara L Kieffer; Shelley George; Robert S Kauffman; Stefan Zeuzem
Journal:  N Engl J Med       Date:  2011-06-23       Impact factor: 91.245

8.  Estimated HIV incidence in the United States, 2006-2009.

Authors:  Joseph Prejean; Ruiguang Song; Angela Hernandez; Rebecca Ziebell; Timothy Green; Frances Walker; Lillian S Lin; Qian An; Jonathan Mermin; Amy Lansky; H Irene Hall
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.